




Instance: composition-en-11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: CompositionUvEpi
Title: "Composition for cystadane Package Leaflet"
Description:  "Composition for cystadane Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp9af3a2b90733a985bf53ac6bcd03cbba)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cystadane"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Cystadane is and what it is used for </li>
<li>What do you need to know before you take Cystadane </li>
<li>How to take Cystadane </li>
<li>Possible side effects </li>
<li>How to store Cystadane </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What cystadane is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cystadane is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cystadane contains betaine anhydrous which is intended to be an adjunctive treatment of 
homocystinuria, an inherited (genetic) disease where the amino acid methionine cannot be broken 
down completely by the body. </p>
<p>Methionine is present in regular food protein (e.g. meat, fish, milk, cheese, eggs). It is converted into 
homocysteine which is then normally converted into cysteine during digestion. Homocystinuria is a 
disease caused by the accumulation of homocysteine which is not converted to cysteine and is 
characterised by formation of clots in the veins, bone weakness, and skeletal and crystalline lens 
abnormalities. The use of Cystadane together with other treatments such as vitamin B6, vitamin B12, 
folate and a specific diet aims to reduce the elevated homocysteine levels in your body.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Cystadane 
If you are allergic to betaine anhydrous. </p>
<p>Warnings and precautions<br />
Talk to your doctor or pharmacist before taking Cystadane. 
If you notice side effects like headaches, vomiting or a change in your vision and you are of the 
homocystinuria subtype called CBS (cystathionine beta-synthase deficiency), please contact your 
doctor immediately, they could be signs of a swelling in the brain (cerebral oedema). In that case your 
doctor will monitor your methionine level in your body and may review your diet. Your treatment 
with Cystadane may need to be interrupted. 
If you are treated with Cystadane and with an amino-acid mixture and if you need to take other 
medicines at the same time, leave 30 minutes between the intake (see  section  Other medicines and 
Cystadane ). </p>
<p>Other medicines and Cystadane 
Tell your doctor if you are taking, have recently taken or might take any other medicines. 
If you are taking amino-acid mixture or medicines such as vigabatrin or Gaba analogues (medicine 
used to treat epilepsy), please tell your doctor as they might interact with your treatment with 
Cystadane. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before taking this medicine. Your doctor will decide if you can use this 
medicine during pregnancy and breast-feeding. </p>
<p>Driving and using machines 
Cystadane has no or negligible influence on the ability to drive and use machines.  </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>The use of this medicine will be supervised by a doctor experienced in the treatment of patients with 
homocystinuria. 
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure.  </p>
<p>The recommended dose in children and adults is 100mg/kg/day divided in 2 dosesper day. In some 
patients doses above 200 mg/ kg/day were needed to reach therapeutic goals. Your doctor may adapt 
the dose depending on your laboratory values.  </p>
<p>You will therefore need regular blood tests to determine the correct daily dose. </p>
<p>You should take Cystadane orally (by mouth). 
To measure the dose:  </p>
<p>shake the bottle lightly before opening </p>
<p>take the correct measuring spoon:  </p>
<p>the small green spoon measures  100 mg of betaine anhydrous powder;  </p>
<p>the middle size blue spoon measures  150 mg of betaine anhydrous powder ; </p>
<p>the large pink spoon measures 1 g of betaine anhydrous powder. </p>
<p>take a heaped spoonful of powder out of the bottle </p>
<p>pass the flat back of a knife over the top of the spoon </p>
<p>the powder left in the spoon is one spoonful </p>
<p>take the correct number of spoonfuls of powder from the bottle </p>
<p>Mix the measured dose of powder with water, juice, milk, formula or food until completely dissolved 
and ingest immediately after mixing. </p>
<p>If you take more Cystadane than you should 
If you accidentally take too much Cystadane, talk to a doctor or pharmacist immediately. </p>
<p>If you forget to take Cystadane 
Do not take a double dose to make up for forgotten doses. If you forget to take a dose take it as soon as 
you remember it and continue the next dose as planned. </p>
<p>If you stop taking Cystadane </p>
<p>Do not stop the treatment without consulting your doctor. Contact your doctor or pharmacist before 
stopping. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The most commonly side effect when taking Cystadane which may affect more than 1 in 10 people 
(frequency very common) is elevated levels of methionine in the blood.<br />
Methionine level can be related to swelling in the brain (cerebral swelling), which may affect up to 1 
in 100 people (frequency uncommon). If you experience morning headaches with vomiting and/or 
visual changes, contact immediately your doctor (they could be signs of a swelling in the brain). </p>
<p>Gastrointestinal disorders like diarrhoea, nausea, vomiting, stomach discomfort and inflammation of 
the tongue may occur uncommonly (may affect up to 1 in 100 people).<br />
Other uncommon side effects (may affect up to 1 in 100 people) may include decreased appetite 
(anorexia), agitation, irritability, hair loss, hives, skin odour abnormal, lack of control over passing 
urine (urinary incontinence). </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the bottle label and the carton after 
EXP. The expiry date refers to the last day of that month. </p>
<p>Do not store above 25 C. 
Keep the bottle tightly closed in order to protect from moisture. 
After the first opening of the bottle, the medicine should be used within 3 months. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Cystadane contains 
- The active substance is betaine anhydrous. 1 g of oral powder contains 1 g of betaine anhydrous.<br />
- There is no other ingredient. </p>
<p>What Cystadane looks like and contents of the pack 
Cystadane is a white crystalline free flowing powder. It is presented in bottles with child resistant 
closures. Each bottle contains 180 g of powder. Each carton contains one bottle and three measuring 
spoons. </p>
<p>Marketing Authorisation Holder 
Recordati Rare Diseases 
Immeuble  Le Wilson<br />
70, avenue du General de Gaulle<br />
F-92 800 Puteaux 
France </p>
<p>Manufacturer 
Recordati Rare Diseases 
Immeuble  Le Wilson<br />
70, avenue du G n ral de Gaulle 
F-92800 Puteaux 
France </p>
<p>or </p>
<p>Recordati Rare Diseases 
Eco River Parc 
30, rue des Peupliers 
F-92000 Nanterre 
France </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder. </p>
<p>Belgique/Belgi /Belgien 
Recordati<br />
T l/Tel: +32 2 46101 Belgique 
Lietuva 
Recordati AB. 
Tel: + 46 8 545 80  vedija </p>
<p>Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64    </p>
<p>Luxembourg/Luxemburg 
Recordati<br />
T l/Tel: +32 2 46101 Belgique/Belgien 
 esk  republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francie </p>
<p>Magyarorsz g 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franciaorsz g 
Danmark 
Recordati AB. 
Tlf : +46 8 545 80 Sverige </p>
<p>Malta 
Recordati Rare Diseases 
Tel: +33 1 47 73 64 Franza </p>
<p>Deutschland 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 </p>
<p>Nederland 
Recordati<br />
Tel: +32 2 46101 Belgi  </p>
<p>Eesti 
Recordati AB. 
Tel: + 46 8 545 80 Rootsi 
Norge 
Recordati AB. 
Tlf : +46 8 545 80 Sverige  </p>
<p>Recordati Rare Diseases 
 : +33 (0)1 47 73 64   </p>
<p>sterreich 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Deutschland </p>
<p>Espa a 
Recordati Rare Diseases Spain S.L.U. 
Tel: + 34 91 659 28 Polska 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francja  </p>
<p>France 
Recordati Rare Diseases 
T l: +33 (0)1 47 73 64 Portugal 
Jaba Recordati S.A. 
Tel: +351 21 432 95 Hrvatska 
Recordati Rare Diseases 
T l: +33 (0)1 47 73 64 Francuska </p>
<p>Rom nia 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Fran a<br />
Ireland 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 France </p>
<p>Slovenija 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francija  </p>
<p>sland 
Recordati AB. 
Simi:+46 8 545 80 Sv j  </p>
<p>Slovensk  republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franc zsko  </p>
<p>Italia 
Recordati Rare Diseases Italy Srl 
Tel: +39 02 487 87 Suomi/Finland 
Recordati AB. 
Puh/Tel : +46 8 545 80 Sverige </p>
<p>Recordati Rare Diseases 
  : +33 1 47 73 64   </p>
<p>Sverige 
Recordati AB. 
Tel : +46 8 545 80 Latvija 
Recordati AB. 
Tel: + 46 8 545 80 United Kingdom 
Recordati Rare Diseases UK Ltd. 
Tel: +44 (0)1491 414Zviedrija </p>
<p>This leaflet was last revised in  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: CompositionUvEpi
Title: "Composition for cystadane Package Leaflet"
Description:  "Composition for cystadane Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp9af3a2b90733a985bf53ac6bcd03cbba)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cystadane"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Cystadanes virkning og hvad du skal bruge det til 
2. Det skal du vide, før du begynder at tage Cystadane 
3. Sådan skal du tage Cystadane 
4. Bivirkninger 
5. Sådan opbevarer du Cystadane 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What cystadane is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cystadane is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cystadane indeholder betain, vandfrit, der skal bruges som tillægsbehandling af homocysteinuria, en 
nedarvet (genetisk) sygdom, hvor aminosyren methionin ikke kan nedbrydes fuldstændigt af kroppen. </p>
<p>Methionin findes i almindelige fødevarer (fx kød, fisk, mælk, ost og æg). I kroppen kan det først 
ændres til stoffet homocystein og derefter til stoffet cystein. Homocysteinuria er en sygdom, hvor der 
er for meget homocystein, som ikke ændres til cystein. De typiske tegn på homocysteinuria er 
blodpropper i årene, skøre knogler, ændringer af skelettet og i øjets linse. Brug af Cystadane sammen 
med anden behandling som vitamin B6, vitamin B12, folinsyre og en speciel kost vil sænke et forhøjet 
indhold af homocystein i din krop.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Cystadane 
Hvis du er allergisk over for betain, vandfri. </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før du tager Cystadane.<br />
Hvis du har bemærket bivirkninger i form af hovedpine, opkastning eller ændringer af dit syn, og du 
tilhører undergruppen med homocystinuri, også kaldet CBS (cystathionin-beta-synthase-mangel), skal 
du straks kontakte din læge, idet det kan være tegn på hævelse i hjernen (cerebralt ødem). I det 
tilfælde vil din læge overvåge methioninniveauet i din krop og muligvis gennemgå din diæt. Det er 
muligt at din behandling med Cystadane skal stoppes.<br />
Hvis du behandles med Cystadane og en aminosyreblanding og hvis du tager anden medicin samtidig 
skal du vente 30 minutter mellem at du tager dem (se afsnittet "Brug af anden medicin sammen med 
Cystadane"). </p>
<p>Brug af anden medicin sammen med Cystadane 
Fortæl det til lægen, hvis du bruger anden medicin eller har brugt det for nylig eller måske vil gøre det. 
Hvis du tager en aminosyreblanding eller medicin så som vigabatrin eller GABA-analoger (medicin, 
der bruges til behandling af epilepsi), skal du straks fortælle det til din læge, fordi de kan påvirke din 
behandling med Cystadane. </p>
<p>Graviditet og amning 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge til råds, før du bruger dette lægemiddel. 
Din læge vil afgøre, om du må bruge dette lægemiddel, mens du er gravid eller ammer. </p>
<p>Trafik- og arbejdssikkerhed 
Cystadane påvirker ikke eller i ubetydelig grad evnen til at føre motorkøretøj eller betjene maskiner. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brugen af medicinen følges af en læge, der har erfaring med at behandle patienter med 
homocysteinuria. 
Tag altid dette lægemiddel nøjagtigt efter lægens eller apotekets anvisning. Er du i tvivl så spørg 
lægen eller apoteket. </p>
<p>Den anbefalede dosis hos børn og voksne er 100 mg/kg/dag fordelt på 2 doser om dagen. Hos visse 
patienter var der behov for doser over 200 mg/kg/dag for at nå de terapeutiske mål. Din læge kan 
tilpasse dosen i forhold til dine laboratorieværdier. 
Du skal derfor have taget regelmæssige blodprøver for at bestemme den korrekte daglige dosis.  </p>
<p>Du skal tage Cystadane oralt (via munden). 
Dosen bestemmes ved at: 
 
Ryst flasken let før åbning, 
 
Tag den korrekte måleske: * Den lille måleske svarer til 100 mg betain, vandfrit pulver * Den midterste måleske svarer til 150 mg betain, vandfrit pulver * Den store måleske svarer til 1 g betain, vandfrit pulver. 
 
Tag en toppet måleskefuld fra flasken,<br />
 
Stryg en glat overflade, fx kanten af en kniv henover kanten af måleskeen, 
 
Det pulver, der er tilbage i måleskeen giver en skefuld<br />
 
Tag det korrekte antal skefulde fra flasken.  </p>
<p>Pulveret blandes med vand, juice, mælk, opskrifter eller mad indtil det er helt opløst og indtages lige 
efter opblanding. </p>
<p>Hvis du har taget for meget Cystadane 
Hvis du kommer til at tage for meget Cystadane, skal du straks tale med din læge eller apoteket. </p>
<p>Hvis du har glemt at tage Cystadane 
Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis. Hvis du har glemt at tage en 
dosis, skal du tage den, så snart du kommer i tanke om det, og fortsætte med næste dosis efter planen. </p>
<p>Hvis du holder op med at tage Cystadane 
Du må ikke holde op med behandlingen uden at rådføre dig med din læge. Kontakt din læge eller 
apoteket, inden du holder op. </p>
<p>Spørg lægen eller apoteket hvis der er noget, du er i tvivl om eller følger dig usikker på. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Den mest almindelige bivirkning ved brug af Cystadane, som kan ramme mere end 1 ud af personer (hyppighed meget almindelig), er forhøjede methioninniveauer i blodet. 
Methioninniveauet kan være forbundet med hævelse i hjernen (cerebral hævelse), hvilket kan ramme 
op til 1 ud af 100 personer (hyppighed ikke almindelig). Hvis du oplever morgenhovedpine med 
opkastning og/eller synsforandringer, skal du straks kontakte din læge (det kan være tegn på hævelse i 
hjernen). </p>
<p>Mave-tarm-lidelser som for eksempel diaré, kvalme, opkastning, maveubehag og betændelse i tungen<br />
kan forekomme, men er ikke almindelige (kan ramme op til 1 ud af 100 personer). Andre ikke-
almindelige bivirkninger (kan ramme op til 1 ud af 100 personer) kan for eksempel være nedsat 
appetit (anoreksi), uro, irritabilitet, hårtab, nældefeber, unormal lugt fra huden, manglende 
blærekontrol (urininkontinens). </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan 
også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cystadane"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cystadane"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar dette lægemiddel utilgængeligt for børn. </p>
<p>Brug ikke dette lægemiddel efter den udløbsdato, der står på pakningen. Udløbsdatoen er den sidste 
dag i den nævnte måned. </p>
<p>Må ikke opbevares over 25°C 
Hold flasken godt lukket for at beskytte imod fugt. 
Efter første åbning af flasken skal lægemidlet bruges i løbet af 3 måneder. </p>
<p>Spørg på apoteket hvordan du skal aflevere medicinrester. Af hensyn til miljøet må du ikke smide 
medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cystadane indeholder:</p>
<ul>
<li>Det aktive stof er betain, vandfrit. 1 g oralt pulver indeholder 1 g betain, vandfri. </li>
<li>Der er ikke andre indholdsstoffer.  </li>
</ul>
<p>Cystadanes udseende og pakningsstørrelse 
Cystadane er et hvidt krystallinsk frit strømmende pulver. Det findes i flasker med en børnesikret 
lukning. Hver flaske indeholder 180 g pulver. Hver æske indeholder en flaske og tre måleskeer. </p>
<p>Indehaveren af markedsføringstilladelsen 
Recordati Rare Diseases 
Immeuble “Le Wilson" 
70, Avenue du General de Gaulle<br />
F-92 800 Puteaux<br />
Frankrig </p>
<p>Fremstiller 
Recordati Rare Diseases 
Immeuble “Le Wilson" 
70, Avenue du General de Gaulle<br />
F-92 800 Puteaux<br />
Frankrig </p>
<p>Eller </p>
<p>Recordati Rare Diseases 
Eco River Parc 
30, rue des Peupliers 
F-92000 Nanterre 
Frankrig </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant: </p>
<p>Belgique/België/Belgien 
Recordati 
Tél/Tel: +32 2 46101 Lietuva 
Recordati AB. 
Tel: + 46 8 545 80 Švedija </p>
<p>България 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Франция  </p>
<p>Luxembourg/Luxemburg 
Recordati<br />
Tél/Tel: +32 2 46101 Belgique/Belgien 
Česká republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 58<br />
Francie </p>
<p>Magyarország 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franciaország 
Danmark 
Recordati AB. 
Tlf : +46 8 545 80 230<br />
Sverige </p>
<p>Malta 
Recordati Rare Diseases 
Tel: +33 1 47 73 64 Franza </p>
<p>Deutschland 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Nederland 
Recordati<br />
Tel: +32 2 46101 België </p>
<p>Eesti 
Recordati AB. 
Tel: + 46 8 545 80 230<br />
Rootsi </p>
<p>Norge 
Recordati AB. 
Tlf : +46 8 545 80 Sverige  </p>
<p>Ελλάδα 
Recordati Rare Diseases 
Τηλ: +33 (0)1 47 73 64 Γαλλία </p>
<p>Österreich 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Deutschland </p>
<p>España 
Recordati Rare Diseases Spain S.L.U. 
Tel: + 34 91 659 28 Polska 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francja  </p>
<p>France 
Recordati Rare Diseases 
Tél: +33 (0)1 47 73 64<br />
Portugal 
Jaba Recordati S.A.<br />
Tel: +351 21 432 95<br />
Hrvatska 
Recordati Rare Diseases 
Tél: +33 (0)1 47 73 64 Francuska </p>
<p>România 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franţa<br />
Ireland 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 58 <br />
France </p>
<p>Slovenija 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 58<br />
Francija  </p>
<p>Ísland 
Recordati AB. 
Simi:+46 8 545 80 Svíþjóð </p>
<p>Slovenská republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 58<br />
Francúzsko  </p>
<p>Italia 
Recordati Rare Diseases Italy Srl 
Tel: +39 02 487 87<br />
Suomi/Finland 
Recordati AB. 
Puh/Tel : +46 8 545 80 Sverige </p>
<p>Κύπρος 
Recordati Rare Diseases 
Τηλ : +33 1 47 73 64 Γαλλία </p>
<p>Sverige 
Recordati AB. 
Tel : +46 8 545 80  </p>
<p>Latvija 
Recordati AB. 
Tel: + 46 8 545 80 United Kingdom 
Recordati Rare Diseases UK Ltd. 
Tel: +44 (0)1491 414Zviedrija </p>
<p>Denne indlægsseddel blev senest ændret den  </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu/. Der er også links til websites om sjældne sygdomme, og 
hvordan de behandles. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cystadane Package Leaflet for language en"
Description: "ePI document Bundle for cystadane Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-11f43ece9ca4cf7aa03a029895a8e969"
* entry[0].resource = composition-en-11f43ece9ca4cf7aa03a029895a8e969

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp11f43ece9ca4cf7aa03a029895a8e969"
* entry[=].resource = mp11f43ece9ca4cf7aa03a029895a8e969
                            
                    
Instance: bundlepackageleaflet-da-11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cystadane Package Leaflet for language da"
Description: "ePI document Bundle for cystadane Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-11f43ece9ca4cf7aa03a029895a8e969"
* entry[0].resource = composition-da-11f43ece9ca4cf7aa03a029895a8e969

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp11f43ece9ca4cf7aa03a029895a8e969"
* entry[=].resource = mp11f43ece9ca4cf7aa03a029895a8e969
                            
                    



Instance: mp11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Cystadane 1 g oral powder"
Description: "Cystadane 1 g oral powder"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/06/379/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Cystadane 1 g oral powder"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 11f43ece9ca4cf7aa03a029895a8e969ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "cystadane"

* status = #current
* mode = #working

* title = "List of all ePIs associated with cystadane"

* subject = Reference(mp9af3a2b90733a985bf53ac6bcd03cbba)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#cystadane "cystadane"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-11f43ece9ca4cf7aa03a029895a8e969) // cystadane en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-11f43ece9ca4cf7aa03a029895a8e969) // cystadane da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-11f43ece9ca4cf7aa03a029895a8e969
InstanceOf: List

* insert 11f43ece9ca4cf7aa03a029895a8e969ListRuleset
    